Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 12/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.51 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.51 |
| ▸ | POLA1 | P09884 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4619794 | 0.91 | P2RY6 (0.55) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8440658 | 0.90 | P2RY6 (0.54) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL28293726 | 0.89 | P2RY6 (0.58) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8436036 | 0.88 | P2RY6 (0.58) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8441389 | 0.86 | P2RY6 (0.56) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8441421 | 0.85 | P2RY6 (0.49) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8437011 | 0.85 | P2RY6 (0.54) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL4348236 | 0.85 | P2RY6 (0.54) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL8440847 | 0.84 | P2RY6 (0.49) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL26676224 | 0.84 | P2RY6 (0.59) | P2RY6P2RY2P2RY4POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132448-A1 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260125752-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260126354-A1 | TISSUE TRANSFER HYDROGEL DEVICES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4720332-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | Singular Genomics Systems, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092317-A1 | TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12577611-B2 | Methods for in situ transcriptomics and proteomics | Singular Genomics Systems, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12529093-B2 | Detecting tumor infiltrating cells | Singular Genomics Systems, Inc. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20260016378-A1 | DEVICES USEFUL FOR TISSUE SAMPLE MANIPULATION | Singular Genomics Systems, Inc. | 2026-01-15 | — | — | US | disclosed |
| US-20260009069-A1 | MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOF | Singular Genomics Systems, Inc. | 2026-01-08 | — | — | US | disclosed |
| EP-4673563-A2 | TARGETED SPATIAL SEQUENCING | Singular Genomics Systems, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| US-20040115643-A1 | Thermodynamic equilibrium extension of primers | YALE UNIVERSITY | 2004-06-17 | — | — | US | disclosed |
| WO-2004027035-A2 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES. | YALE UNIVERSITY (US) | 2004-04-01 | — | — | WO | disclosed |
| US-20030228613-A1 | Nucleic acid amplification | QIAGEN GMBH (DE) | 2003-12-11 | — | — | US | disclosed |
| US-6617137-B2 | During replication at least one of the replicated strands is displaced from the genome by strand displacement replication of another replicated strand. | MOLECULAR STAGING INC. | 2003-09-09 | — | — | US | disclosed |
| WO-2003066908-A1 | DETECTION METHOD USING DISSOCIATED ROLLING CIRCLE AMPLIFICATION | MOLECULAR STAGING, INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| US-20030152932-A1 | Detection method using dissociated rolling circle amplification | QIAGEN GMBH (DE) | 2003-08-14 | — | — | US | disclosed |
| US-20030143587-A1 | Nucleic acid amplification | MOLECULAR STAGING, INC. | 2003-07-31 | — | — | US | disclosed |
| US-20030118998-A1 | Nucleic acid amplification | QIAGEN GMBH (DE) | 2003-06-26 | — | — | US | disclosed |
| EP-0933375-A1 | Photochromic compounds | Amersham Life Science Ltd (GB) | 1999-08-04 | — | — | EP | disclosed |
| WO-1999031107-A1 | PHOTOCHROMIC COMPOUNDS | AMERSHAM PHARMACIA BIOTECH UK LTD. (GB) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009069-A1 | MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOF | DNMT3A, CALCB, FLT3 | P2RY6 538/4885P2RY2 272/4885P2RY4 551/4885 |
| US-12577611-B2 | Methods for in situ transcriptomics and proteomics | CHAMP1, TUFM, TFAM | P2RY6 2806/4885P2RY2 2555/4885P2RY4 2404/4885 |
| US-20260125752-A1 | METHODS AND PROBES FOR DETECTING POLYNUCLEOTIDE SEQUENCES IN CELLS AND TISSUES | DNMT3L, DNMT3A, FBL | P2RY6 1234/4885P2RY2 1584/4885P2RY4 1345/4885 |
| US-20260126354-A1 | TISSUE TRANSFER HYDROGEL DEVICES | CD68, ACTB, GJA1 | P2RY6 4410/4885P2RY2 3998/4885P2RY4 4490/4885 |
| US-12529093-B2 | Detecting tumor infiltrating cells | MICA, CD74, MCTS1 | P2RY6 1100/4885P2RY2 718/4885P2RY4 739/4885 |
| US-20260016378-A1 | DEVICES USEFUL FOR TISSUE SAMPLE MANIPULATION | CUTA, FSCN1, CALD1 | P2RY6 3208/4885P2RY2 2625/4885P2RY4 2302/4885 |
| US-20260092317-A1 | TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES | POLRMT, SSBP1, TRMT1L | P2RY6 3666/4885P2RY2 3256/4885P2RY4 2595/4885 |
| US-20260132448-A1 | ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS | FLNA, FLNB, PHAX | P2RY6 261/4885P2RY2 253/4885P2RY4 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.